ARTICLE | Management Tracks
J&J’s Kumar becomes Cure’s CEO
Plus Shanton recruits LianBio’s Li and updates from BlueSphere, Valence and Apnimed
October 6, 2022 12:28 AM UTC
Seema Kumar became CEO at Cure, a New York-based incubator from Deerfield Management. Kumar joins Cure from Johnson & Johnson (NYSE:JNJ), where she worked for almost two decades, most recently as global head, office of innovation, global health and scientific engagement.
Hyperuricemia and gout company Shanton Pharma Co. Ltd. hired Bing Li as CEO. Li was CEO of LianBio (NASDAQ:LIAN)...